Financhill
Back

Clearside Biomedical Stock Predictions

Clearside Biomedical Stock Forecast

  • Is Clearside Biomedical Stock Undervalued?
    The current Clearside Biomedical [CLSD] share price is $1.31. The Score for CLSD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CLSD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Clearside Biomedical Stock Go Up Next Year?

Data Unavailable

Clearside Biomedical Stock Rating

Data Unavailable

Clearside Biomedical Stock Price History

Is CLSD stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLSD is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
clearsidebio.com

52-Week Data

52-Week High:
2.12
52-Week Low:
0.65

Prediction Charts

Market Cap:
97.92M
Price in USD:
1.31
Volume:
218.03K
Beta:
1.78

Technical Analysis

SMA50:
1.11
SMA100:
1.19
SMA200:
1.27
52-Wk Change:
54.3%

Stock Predictions

  • Is Clearside Biomedical stock public?
    Yes, Clearside Biomedical is a publicly traded company.
  • What is the Clearside Biomedical stock quote today?
    The Clearside Biomedical stock price is 1.31 USD today.
  • How to buy Clearside Biomedical stock online?
    You can buy Clearside Biomedical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 1.02 1.01 1.02 0.98
Aug-30 1.02 1.01 1.02 1.00
Sep-3 1.03 1.00 1.03 1.00
Sep-4 1.00 0.96 1.00 0.96
Sep-5 0.96 0.92 0.97 0.92
Sep-6 0.94 0.97 1.00 0.94
Sep-9 1.00 1.07 1.12 0.97
Sep-10 1.06 1.13 1.14 1.06
Sep-11 1.13 1.31 1.33 1.10
Sep-12 1.30 1.35 1.38 1.30
Sep-13 1.38 1.23 1.38 1.19
Sep-16 1.28 1.31 1.34 1.26
Sep-17 1.35 1.31 1.38 1.27
Sep-18 1.30 1.31 1.35 1.29

Clearside Biomedical Earnings

Data Unavailable

Clearside Biomedical Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.03 per share, and a decrease next year of $0.01 per share.

* Clearside Biomedical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.